Trials / Unknown
UnknownNCT02301221
Effect of Fecal Microbiota Transplantation in Slow Transit Constipation
A Study of Efficacy, Safety and Durability of Fecal Microbiota Transplantation in Adult Patients With Slow Transit Constipation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of fecal microbiota transplantation in adults with slow transit constipation.
Detailed description
Constipation is a chronic disease estimated to affect about 10% - 15% of the worldwide general population. Constipation frequency appears to augment with increasing age, particularly after 65 years old. Recent evidence in the literature and collected in our laboratory confirm that constipation can be a consequence of intestinal dysbiosis, with an increase of potentially pathogenic microorganisms and a decrease of potentially beneficial microorganisms. These alterations may affect the motility and metabolic environment of colon, especially the production of short chain fatty acids (SCFAs). A new and under-explored method to manipulate the gastrointestinal microbiota involves fecal microbiota transplantation (FMT). There has been growing interest in the use of fecal microbiota for the treatment of patients with chronic gastrointestinal infections (e.g. CDI) and other extraintestinal conditions (e.g. IBD). Similarly, we suppose that reshaping the gut microbiome with FMT would be effective for patients with slow transit constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fecal microbiota transplantation (FMT) | Standardized Frozen Fecal Microbiota will be infused via nasointestinal tube. |
| DRUG | Vancomycin and bowel lavage | An initial vancomycin regimen (500 mg orally two times per day for 3 days), followed by bowel lavage before the infusion of a solution of donor fecal microbiota. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-03-01
- Completion
- 2016-12-01
- First posted
- 2014-11-25
- Last updated
- 2016-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02301221. Inclusion in this directory is not an endorsement.